Skip to content

Author

E. S. Egorova

1 paper indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Sep 2026

Re-Evaluating Multi-Kinase Inhibitors Targeting FGFR and VEGFR Pathways for Combined Therapy in Colorectal Cancer: A Preclinical Study

It is shown that receptor tyrosine kinase inhibitors (RTKIs) designed to inhibit the overactivated FGFR and/or VEGFR signaling pathways exert an “off-target” effect on MDR proteins in colorectal cancer (CRC), thereby sensitizing CRC to certain chemotherapies.

S. Boichuk, T. Gessel, P. Dunaev et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.